Human Pathology
Volume 41, Issue 1 , Page 150 , January 2010

Estrogen receptor immunohistochemistry cutoff value: Standardization is needed

Received 13 July 2009 ,Accepted 20 August 2009.

References 

  1. Williams DJ, Cohen C, To TV, et al. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray. Hum Pathol. 2009;40:1176–1181
  2. Tan DS, Marchió C, Jones RL, et al. Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat. 2008;111:27–44
  3. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer. 2007;109:25–32
  4. Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007;109:1721–1728

PII: S0046-8177(09)00301-3

doi: 10.1016/j.humpath.2009.08.013

Human Pathology
Volume 41, Issue 1 , Page 150 , January 2010

Article Tools